Key Points and Takeaways
- Los Angeles County confirmed its first fatal overdose involving cychlorphine on October 15, 2026. The death occurred in February, but the synthetic opioid was identified and publicly reported later.
- Cychlorphine is a powerful synthetic opioid that has been found in counterfeit prescription medications, including products sold as anxiety medications.
- A separate San Francisco overdose death involving a 16-year-old teenager raised concerns about counterfeit Xanax pills containing unexpected synthetic opioids.
- Conventional fentanyl test strips do not detect cychlorphine, and routine drug screens may also fail to identify the substance.
- How Wildwood Recovery helps: Wildwood provides physician-supervised detox, opioid and prescription drug addiction treatment, medication-assisted treatment (MAT), and continuing recovery support in Thousand Oaks, California.
A pill that looks like Xanax or oxycodone may contain something entirely different. That concern is receiving renewed attention following an announcement from Los Angeles County health officials confirming the area’s first fatal overdose involving cychlorphine, an emerging synthetic opioid described as more potent than fentanyl.
On October 15, 2026, the Los Angeles County Department of Public Health announced that cychlorphine had been identified as a cause of death in an overdose that occurred in February. The substance has also been connected to a teenager’s fatal overdose in San Francisco, where investigators were examining the distribution of counterfeit prescription medications.
For families in Thousand Oaks, Simi Valley, Westlake Village, and surrounding Ventura County communities, the news raises an important concern. People purchasing pills represented as Xanax, oxycodone, or other prescription medications outside licensed pharmacies may have no reliable way to know what they are taking.
Los Angeles County Confirms Its First Fatal Cychlorphine Overdose
The February 2026 Death Was Announced in October Following Toxicology Findings
According to the Los Angeles County Department of Public Health’s October 15 announcement, the county’s Medical Examiner identified cychlorphine, also known as N-propionitrile chlorphine, as a cause of death in a February 2026 overdose.
The finding represented the first confirmed evidence of cychlorphine in Los Angeles County’s illicit drug supply. Health officials said the substance had already been detected in 19 states since appearing in the United States in 2024 and had been identified in powders, counterfeit prescription tablets, crystals, and liquids.
Local news outlet MyNewsLA reported on the overdose, noting that cychlorphine can suppress breathing and is not detected by conventional fentanyl test strips. County officials also warned that combining the substance with alcohol, benzodiazepines, or other sedatives can increase the risk of a fatal overdose.
The announcement did not identify the specific drug product involved in the Los Angeles death. Although cychlorphine has been found in pressed pills, officials have not confirmed that a counterfeit Xanax or oxycodone tablet caused this particular fatality.
This distinction matters because the county confirmed one fatal case, not a widespread outbreak involving a specific pill imprint. However, the warning comes as other California investigations have documented the dangers of counterfeit prescription medications containing unexpected substances.
What Is Cychlorphine, and Why Is It So Dangerous?
Understanding the Emerging Synthetic Opioid Being Compared to Fentanyl
Cychlorphine belongs to a group of synthetic opioids commonly referred to as orphines. Like fentanyl, heroin, and other opioids, it acts on receptors in the brain and nervous system that influence pain perception, sedation, and breathing.
When someone takes too much of an opioid, breathing can become dangerously slow or stop altogether. Without sufficient oxygen, a person may lose consciousness and suffer permanent injury or death.
Los Angeles County health officials describe cychlorphine as more potent than fentanyl. However, human research remains limited, and there is not enough clinical evidence to establish a dependable numerical comparison between the two substances.
Unlike pharmaceutical fentanyl, cychlorphine has no FDA-approved medical use. It was placed under federal Schedule I controls in August 2026 following concerns about its appearance in the illicit drug market and its association with serious overdoses.
| Characteristic | Cychlorphine | Fentanyl |
|---|---|---|
| Drug classification | Synthetic opioid, orphine family | Synthetic opioid, phenylpiperidine family |
| FDA-approved medical use | None | Yes, in regulated prescription formulations |
| Found in counterfeit pills | Yes | Yes |
| Detected by conventional fentanyl strips | No | Generally, within test limitations |
| Primary overdose danger | Respiratory depression | Respiratory depression |
| Can naloxone reverse its opioid effects? | Yes | Yes |
| Reliable human potency comparison | Not established | Clinically characterized |
One major concern is that people may encounter cychlorphine without deliberately seeking it. Unlike someone who knowingly uses an opioid, an individual purchasing what appears to be a prescription anxiety medication may not anticipate opioid exposure at all.
How Is Cychlorphine Connected to Fake Xanax Pills?
Counterfeit Alprazolam May Contain Powerful Opioids Instead of the Expected Medication
Xanax is a brand-name prescription medication containing alprazolam, a benzodiazepine used to treat certain anxiety and panic disorders. It is not an opioid, and legitimate pharmaceutical alprazolam does not contain cychlorphine.
Counterfeit pills, however, may contain entirely different substances from the medications they resemble. Illegal manufacturers can reproduce familiar tablet markings and shapes, making a counterfeit product appear similar to something dispensed by a licensed pharmacy.
Cychlorphine has been documented in products represented as benzodiazepines, and a medical case published in the Journal of Medical Toxicology illustrates the consequences.
Researchers described a woman in her twenties who arrived at an emergency department after taking what she believed was alprazolam. She had become unresponsive and developed respiratory depression, prompting emergency medical personnel to administer naloxone.
Initial urine drug screens were negative for both opiates and fentanyl. More comprehensive laboratory testing identified cychlorphine, along with other substances, including bromazolam, an illicit benzodiazepine.
The case demonstrated that someone could experience serious opioid poisoning after taking what they believed was a benzodiazepine, even when conventional testing initially failed to identify an opioid.
A San Francisco Teenager’s Death Raised Similar Concerns
California had already experienced another fatal overdose involving cychlorphine before the Los Angeles announcement.
In September 2026, ABC7 reported on the death of a 16-year-old San Francisco resident whose toxicology results identified the emerging synthetic opioid.
The teenager died in April, and a subsequent police investigation led to four arrests and the seizure of more than 20,000 suspected counterfeit prescription pills. Police said the teenager’s death involved a combination of drugs, including cychlorphine.
Additional reporting from Axios indicated that the teenager had reportedly taken what he believed was Xanax. The investigation raised concerns about counterfeit medications being distributed through informal markets and social media.
The circumstances of the San Francisco death should not be treated as proof that the same pills or suppliers were responsible for the Los Angeles fatality. The two investigations are separate, although both demonstrate the risks associated with unexpected exposure to powerful synthetic opioids.
Why Familiar Xanax Pill Markings Cannot Guarantee Safety
Wildwood’s Earlier B707 Pill Warning Shows How Counterfeit Medications Can Be Misrepresented
The dangers associated with counterfeit Xanax extend beyond cychlorphine. Other unexpected substances, including designer benzodiazepines, have been discovered in tablets made to resemble legitimate alprazolam.
In August 2026, Wildwood Recovery published an article about blue B707 pills containing unexpected designer benzodiazepines. The article examined a laboratory finding from the Center for Forensic Science Research and Education involving a blue tablet marked B707, an imprint associated with a regulated 2 mg alprazolam product.
Rather than the expected pharmaceutical ingredient, the sample contained two novel benzodiazepines: ethylflualprazolam and 4′-Cl deschloroalprazolam.
That particular sample originated in Georgia, and the laboratory did not report cychlorphine as its finding. It should not be confused with the Los Angeles overdose or the San Francisco investigation.
However, the B707 finding illustrates a broader problem with counterfeit medications. A tablet’s color, shape, score lines, and identifying letters cannot establish what it contains when it comes from an unregulated source.
Someone who believes a familiar imprint guarantees a familiar medication may unknowingly take a drug with different effects, an unpredictable duration, or a substantially different risk profile.
Can Fake Oxycodone Pills Also Contain Cychlorphine?
Blue M30 and RP 10 Counterfeits Raise Similar Concerns About Unexpected Opioids
Counterfeit oxycodone has been a major concern in the United States for years, particularly as illicit fentanyl has become common in tablets sold as prescription pain medication.
Wildwood has previously examined blue M30 pills and counterfeit oxycodone, including the risks associated with tablets made to resemble 30 mg oxycodone.
We have also covered real versus fake RP 10 oxycodone pills, another example of how recognizable pharmaceutical markings can be reproduced on counterfeit products.
Cychlorphine has been found in counterfeit prescription tablets, but the available Los Angeles reporting does not identify a particular M30, RP 10, or other oxycodone imprint involved in the fatality.
The broader concern is that counterfeit-pill manufacturers do not follow the pharmaceutical quality-control standards used by licensed medication manufacturers. Two tablets that look similar may contain different drugs, different concentrations, or combinations of substances.
| Common Assumption | What People Should Know |
|---|---|
| “It looks exactly like Xanax.” | Counterfeit Xanax may contain unexpected benzodiazepines, opioids, or combinations of drugs. |
| “The oxycodone imprint matches online.” | Counterfeit manufacturers can reproduce legitimate tablet markings. |
| “It tested negative for fentanyl.” | Conventional fentanyl strips do not detect cychlorphine or every other dangerous opioid. |
| “They have taken these pills before.” | Ingredients and potency can vary between suppliers, batches, and individual tablets. |
| “It was only one pill.” | A single counterfeit tablet may contain enough of a powerful opioid to cause a fatal overdose. |
The safest way to obtain prescription medication is through a legitimate prescription filled by a licensed pharmacy. A pill purchased through an informal seller or unregulated website should never be assumed authentic based on appearance alone.
Why Cychlorphine May Not Appear on Routine Drug Tests
Fentanyl Test Strips Cannot Detect Every Emerging Synthetic Opioid
Fentanyl test strips have become a common overdose-prevention tool because they can detect fentanyl and certain related compounds. However, they are not designed to identify every drug that can produce opioid effects.
Cychlorphine has a different chemical structure from fentanyl, so conventional fentanyl test strips do not detect it. A sample containing cychlorphine may therefore test negative for fentanyl while still posing a serious overdose risk.
Routine hospital urine drug screens can have similar limitations. These tests identify specific substances or drug classes within their detection capabilities, and newer synthetic opioids may require specialized laboratory methods for confirmation.
The previously described medical case involving a woman who believed she had taken alprazolam illustrates this problem. Despite showing symptoms consistent with opioid poisoning, her initial fentanyl and opiate urine screens were negative. Advanced toxicology testing was necessary to detect cychlorphine.
Los Angeles County has identified Drug Checking LA as a resource for specialized testing. The county reported that testing for cychlorphine could provide results in approximately 15 to 20 minutes, although current availability and arrangements should be confirmed with the program.
Even when drug-checking services are available, a negative result does not establish that an illicit substance is completely safe. Different tests have different detection capabilities, and counterfeit products may contain ingredients that are not evenly distributed.
What Are the Signs of a Cychlorphine Overdose?
Recognizing Opioid Poisoning Before Breathing Stops
A cychlorphine overdose may look similar to an overdose involving fentanyl, heroin, or another powerful opioid. Someone may initially appear extremely tired or heavily intoxicated before becoming difficult to wake or losing consciousness.
The most dangerous effect is respiratory depression, which occurs when breathing becomes too slow or ineffective to supply the body with enough oxygen.
Signs of a possible overdose include:
- Slow, shallow, irregular, or stopped breathing
- Inability to wake someone who appears to be sleeping
- Severe sedation or sudden unconsciousness
- Blue, gray, or unusually pale lips or skin
- Gurgling, choking, or unusual snoring sounds
- Very small pupils, although this is not always present
An unconscious person making gurgling or unusual snoring sounds may not simply be sleeping. These noises can be signs of dangerous breathing problems that require immediate attention.
If an opioid overdose is suspected, call 911 immediately and administer naloxone if available. Follow instructions from emergency dispatch for rescue breathing or CPR, give additional naloxone according to the product instructions if breathing does not return to normal, and remain with the individual until emergency personnel arrive.
Can Narcan Reverse a Cychlorphine Overdose?
Yes. Naloxone, including the nasal spray sold under the brand name Narcan, can reverse the opioid effects of cychlorphine.
Los Angeles County specifically recommends administering naloxone during a suspected cychlorphine overdose and warns that multiple doses may be necessary. Naloxone works by blocking opioid activity at opioid receptors, potentially restoring normal breathing.
However, naloxone does not directly reverse benzodiazepine intoxication or every complication associated with mixed-drug exposure. Someone who has taken a counterfeit pill containing both an opioid and a sedative may require additional emergency treatment.
The Centers for Disease Control and Prevention explains how naloxone can reverse opioid overdoses and emphasizes the importance of emergency assistance.
Even when someone improves after receiving naloxone, medical evaluation remains essential because respiratory depression can return after the medication’s effects wear off.
What Should Parents and Families Do If They Discover Counterfeit Pills?
Responding to Possible Substance Use Without Overlooking an Emergency
Finding unfamiliar prescription pills in a loved one’s possession can be frightening, especially when recent news coverage involves teenagers and young adults who may have unknowingly consumed synthetic opioids.
The first concern should be whether the person is experiencing a medical emergency. If someone is difficult to wake, breathing abnormally, or showing other signs of overdose, call 911 rather than spending time searching for the pill’s identification markings.
When there is no immediate emergency, an open conversation may help establish where the pills came from and whether the person understands the risks. A calm approach can make it easier for someone to discuss substance use, particularly if they are concerned about being judged or punished.
It may be helpful to ask whether the medication came from a licensed pharmacy, how frequently it has been used, and whether the person has experienced withdrawal symptoms or difficulty stopping. These questions can help distinguish an isolated concern from a possible pattern of substance misuse or physical dependence.
Repeated use of counterfeit pills, cravings, withdrawal symptoms, and continued use despite harmful consequences may indicate a need for professional assessment.
Wildwood Recovery offers prescription drug addiction treatment in Thousand Oaks for individuals struggling with opioids, benzodiazepines, and other prescription-related substance use.
Can Someone Become Dependent on Pills Without Knowing What They Contain?
Counterfeit Medication Use Can Complicate Withdrawal and Treatment
One of the challenges associated with counterfeit medications is that someone may develop physical dependence on a substance they never knowingly intended to take.
For example, a person purchasing pills sold as oxycodone may actually be using fentanyl or another synthetic opioid. Someone purchasing counterfeit Xanax may be exposed to benzodiazepines, opioids, or multiple substances at once.
When these products are used repeatedly, the resulting withdrawal symptoms may not match what the person expects from the medication they believe they have been taking.
Opioid withdrawal can cause intense discomfort, cravings, gastrointestinal symptoms, sweating, and other symptoms that make stopping difficult. Returning to opioid use after a period of reduced tolerance can substantially increase overdose risk.
Benzodiazepine withdrawal creates additional concerns. Abrupt discontinuation after sustained physical dependence can lead to serious complications, including seizures, and may require medically supervised tapering.
Because counterfeit pills can contain more than one drug, a comprehensive medical assessment is important before beginning withdrawal management.
How Wildwood Recovery Helps With Counterfeit-Pill and Opioid Addiction
Physician-Supervised Detox, Medication-Assisted Treatment, and Individualized Recovery Care
At Wildwood Recovery, treatment begins with an individualized assessment of substance use, medical history, withdrawal symptoms, and co-occurring mental health concerns. Someone who has been using counterfeit pills may need care for opioid use disorder, benzodiazepine dependence, or exposure to multiple substances.
Our physician-supervised detox program in Thousand Oaks helps individuals manage the physical symptoms of withdrawal while receiving ongoing medical monitoring. The appropriate detoxification plan depends on the substances involved, the person’s health, and the severity of their dependence.
For individuals experiencing opioid use disorder, medication-assisted treatment may also be recommended. Wildwood offers FDA-approved medication options, including extended-release buprenorphine such as Sublocade, when clinically appropriate.
These medications are not cychlorphine-specific antidotes. Rather, they are established treatment options for opioid use disorder that can help reduce cravings, address withdrawal symptoms, and support recovery when prescribed as part of an individualized treatment plan.
For people who have also been using counterfeit benzodiazepines, Wildwood offers benzodiazepine addiction treatment, including medically supervised withdrawal management when needed.
Treatment may continue through residential rehabilitation, outpatient programming, individual therapy, group counseling, family support, and relapse-prevention planning. These services help clients address both physical dependence and the circumstances that contributed to continued substance use.
Wildwood’s aftercare and discharge planning also helps clients prepare for continued recovery after completing a higher level of treatment. Ongoing appointments, recovery connections, and appropriate outpatient referrals can provide additional support during the transition back into everyday life.
Not everyone who accidentally encounters cychlorphine has an addiction, and an overdose does not automatically mean someone has opioid use disorder. However, for individuals who are repeatedly using counterfeit pills, experiencing withdrawal, or struggling to stop using opioids, professional assessment can help determine an appropriate next step.
Get Help for Opioid or Prescription Drug Addiction in Thousand Oaks
Wildwood Recovery provides addiction treatment for individuals in Thousand Oaks, Westlake Village, Simi Valley, the Conejo Valley, and surrounding Southern California communities. Whether someone has been taking counterfeit Xanax, oxycodone, fentanyl, or other substances, our team can help discuss available treatment options.
Call Wildwood Recovery at (805) 301-6862 to learn about medical detox, residential rehabilitation, medication-assisted treatment, and continuing recovery support.
Frequently Asked Questions About Cychlorphine and Counterfeit Pills
Has Cychlorphine Caused an Overdose Death in Los Angeles?
Yes. Los Angeles County confirmed its first fatal cychlorphine overdose on October 15, 2026. The death occurred in February, and the Medical Examiner subsequently identified cychlorphine as a cause of death.
Has Cychlorphine Been Found in Fake Xanax Pills?
Cychlorphine has been associated with counterfeit prescription benzodiazepines. A published medical case documented opioid poisoning in a woman who believed she had taken alprazolam, with comprehensive toxicology testing subsequently identifying cychlorphine.
Did a Teenager Die From Cychlorphine in California?
Yes. San Francisco officials linked the April 2026 death of a 16-year-old teenager to a combination of drugs that included cychlorphine. News coverage indicated that the teenager had reportedly taken what he believed was Xanax.
Can Counterfeit Oxycodone Pills Contain Cychlorphine?
Cychlorphine has been identified in counterfeit prescription tablets, although it has not been established that every common oxycodone-style counterfeit contains the substance. Pills obtained from unregulated sources may contain different drugs from those advertised.
Can Fentanyl Test Strips Detect Cychlorphine?
No. Conventional fentanyl test strips do not detect cychlorphine. A negative fentanyl result cannot rule out other dangerous synthetic opioids or establish that an unregulated pill is safe.
Is Cychlorphine Stronger Than Fentanyl?
Los Angeles County health officials describe cychlorphine as more potent than fentanyl. However, human research remains limited, and there is insufficient evidence to establish a dependable numerical potency comparison.
Does Narcan Work for a Cychlorphine Overdose?
Naloxone can reverse the opioid effects of cychlorphine. Multiple doses and emergency breathing support may be necessary, making it essential to call 911 during a suspected overdose.
Can Medication-Assisted Treatment Help Someone Dependent on Counterfeit Opioid Pills?
Yes. When counterfeit-pill use results in opioid use disorder, FDA-approved medications such as buprenorphine may be appropriate as part of a comprehensive treatment plan. Medical detox, behavioral therapy, residential rehabilitation, and continuing recovery support may also be recommended based on clinical needs.
Sources and References
Public Health Reports, News Coverage, and Medical Research
Centers for Disease Control and Prevention. (2024, May 2). 5 things to know about naloxone.
https://www.cdc.gov/overdose-prevention/reversing-overdose/about-naloxone.html
Kusko, R., Liss, D., House, S. L., House, S. B., Krotulski, A., Aldy, K., & Toxicology Investigators Consortium (ToxIC) Fentalog Study Group. (2026). An emerging synthetic opioid in the drug supply: A case of opioid overdose with biological confirmation of cychlorphine. Journal of Medical Toxicology, 22(4), 490–492.
https://doi.org/10.1007/s13181-026-01146-4
Lopez, N. (2026, October 8). What to know about cychlorphine. Axios.
https://www.axios.com/local/san-francisco/2026/10/08/san-francisco-cychlorphine-drug-overdoses
Los Angeles County Department of Public Health. (2026, October 15). First fatal overdose tied to potent opioid cychlorphine reported in Los Angeles County.
https://lacounty.gov/2026/10/15/first-fatal-overdose-tied-to-potent-opioid-cychlorphine-reported-in-los-angeles-county/
MyNewsLA. (2026, October 15). LACo health officials report first fatal overdose from potent synthetic opioid.
https://mynewsla.com/health-and-wellness/2026/10/15/la-county-reports-first-fatal-overdose-linked-to-potent-synthetic-opioid/
O’Donnell, J., Tanz, L. J., Miller, K. D., Dinwiddie, A. T., Wolff, J., Mital, S., Obiekwe, R., & Mattson, C. L. (2023). Drug overdose deaths with evidence of counterfeit pill use — United States, July 2019–December 2021. Morbidity and Mortality Weekly Report, 72(35), 949–956.
https://www.cdc.gov/mmwr/volumes/72/wr/mm7235a3.htm
Peña, L. (2026, September 15). New circulating opioid stronger than fentanyl linked to San Francisco teen’s death; 4 arrested. ABC7/KGO-TV.
https://abc7news.com/post/cychlorphine-new-opioid-stronger-fentanyl-linked-san-francisco-teens-overdose-death-mayor-daniel-lurie-says-4-arrested/19832337/
San Francisco Police Department. (2026, September 14). SFPD arrests 4 dealers, seizes over 20,000 counterfeit pills, multiple firearms.
https://www.sanfranciscopolice.org/news/sfpd-arrests-4-dealers-seizes-over-20000-counterfeit-pills